Fully Automated Water Conductivity Testing Safeguards Compliance with USP 645
Mar 01 2019 Read 414 Times
USP 645 describes conductivity as key parameter for measuring the purity of ultrapure water and water for injection. Compliance with USP 645 is key for manufacturers from the pharmaceutical industry. However, following the three stage test procedure defined by the standard can be a challenge, particularly if the testing is performed manually. A dedicated Metrohm system provides a fully automated solution to this challenge reducing the risk of error while increasing productivity.
USP 645 describes a cascade of three tests, which have to be performed in sequence. If testing at stage one fails, the procedure defined for stage-two testing has to be performed, which in case of failure has to be followed by the stage-three testing. Failure at stage three equals an out of spec sample. The risk of human error is considerable at each stage, as thorough working is required and conditions must be met such as a maintaining a specific temperature in the solution.
The Metrohm system for conductivity testing according to USP 645 provides a fully automated solution to this challenge. All that is required from the operator is filling the sample into a beaker and placing it on the system’s autosampler. Conductivity testing in whole series of samples is then performed completely unattended while tiamo software makes sure data integrity is maintained and compliance with regulatory standards such as FDA 21 CFR Part 11 is met.
Download the Application note here.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Translating Proteomic MALDi Tissue Typing to Clinical Pathology - Fusion Protein Complexes Analysed by CG-MALS - The Separation and Purification of Glutamine Deri...
View all digital editions
Nov 18 2019 Dusseldorf, Germany
Nov 19 2019 Frankfurt am Main, Germany
Nov 20 2019 Tokyo, Japan
Nov 25 2019 Beijing, China
Dec 05 2019 New Delhi, India